Smoking, alcohol consumption and betel nut chewing are some of the lifestyle factors that have been linked to head and neck ...

Phase 2 study, led by Dr. Antonio Jimeno at the University of Colorado Anschutz Medical Campus will evaluate NT219 in ...

MSD has received US Food and Drug Administration (FDA) approval for its anti-programmed death receptor-1 (PD-1) therapy, ...

Pembrolizumab, an immune checkpoint inhibitor, has been approved by the US Food and Drug Administration for the treatment of ...

Reduce your other risk factors. Tobacco and alcohol use are some of the strongest lifestyle risk factors for head and neck cancer. In a recent study, tobacco use increased the risk of developing ...

Merck & Co.’s Keytruda has become the first immunotherapy approved by the FDA to be used around surgery to treat resectable ...

There are a number of things to look out for, but many of them often go ignored, according to leading oncologist Dr Jiri ...

Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...

The KEYNOTE-689 study showed pembrolizumab with standard of care significantly improved outcomes for resectable HNSCC, ...

Douglas Adkins, MD, discusses future directions of the KEYNOTE-689 trial of pembrolizumab in head and neck cancer following the agent's FDA approval.

Artificial intelligence (AI) tools such as deep learning-based algorithms can be valuable as previous studies have shown a reduction in contouring time and variation. Furthermore, explainable AI (XAI) ...

When facing a cancer diagnosis, the usual treatment modalities are surgery, chemotherapy, or radiation therapy. But what if there was another powerful weapon in the fight against cancer you haven’t ...